CEL-SCI Corp. (CVM)
1.62
+0.01
(+0.62%)
USD |
NYAM |
Aug 27, 16:00
1.62
0.00 (0.00%)
After-Hours: 16:40
CEL-SCI Total Liabilities (Quarterly) : 10.40M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.40M |
| March 31, 2026 | 10.83M |
| December 31, 2025 | 11.76M |
| September 30, 2025 | 12.20M |
| June 30, 2025 | 13.31M |
| March 31, 2025 | 13.81M |
| December 31, 2024 | 14.39M |
| September 30, 2024 | 14.12M |
| June 30, 2024 | 15.60M |
| March 31, 2024 | 15.74M |
| December 31, 2023 | 16.06M |
| September 30, 2023 | 17.31M |
| June 30, 2023 | 17.53M |
| March 31, 2023 | 18.05M |
| December 31, 2022 | 17.97M |
| September 30, 2022 | 18.36M |
| June 30, 2022 | 18.16M |
| March 31, 2022 | 19.03M |
| December 31, 2021 | 18.32M |
| September 30, 2021 | 19.34M |
| June 30, 2021 | 19.85M |
| March 31, 2021 | 19.03M |
| December 31, 2020 | 20.78M |
| September 30, 2020 | 20.81M |
| June 30, 2020 | 23.02M |
| Date | Value |
|---|---|
| March 31, 2020 | 22.51M |
| December 31, 2019 | 22.54M |
| September 30, 2019 | 22.49M |
| June 30, 2019 | 27.34M |
| March 31, 2019 | 23.80M |
| December 31, 2018 | 23.23M |
| September 30, 2018 | 29.59M |
| June 30, 2018 | 22.95M |
| March 31, 2018 | 26.15M |
| December 31, 2017 | 27.01M |
| September 30, 2017 | 26.26M |
| June 30, 2017 | 26.91M |
| March 31, 2017 | 24.91M |
| December 31, 2016 | 18.56M |
| September 30, 2016 | 25.57M |
| June 30, 2016 | 18.25M |
| March 31, 2016 | 18.46M |
| December 31, 2015 | 16.45M |
| September 30, 2015 | 20.68M |
| June 30, 2015 | 17.57M |
| March 31, 2015 | 12.38M |
| December 31, 2014 | 7.714M |
| September 30, 2014 | 8.787M |
| June 30, 2014 | 10.12M |
| March 31, 2014 | 14.46M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.36M |
| Shareholders Equity (Quarterly) | 10.96M |
| Debt to Equity Ratio | 0.721 |
| Current Ratio | 1.477 |
| Net Debt Paydown Yield | 2.88% |